A Texas aesthetics practice with a full injectables book has already solved the hard part: people trust you enough to let you treat them. The next revenue line is usually medical weight management and hormone therapy — recurring, high-retention, and clinically adjacent to what you already do.
Here is what it takes structurally, what it changes commercially, and where the margin actually comes from.
Why these two services
Injectables are episodic. A patient comes in every three to four months, and the relationship is transactional by design.
Weight management and hormone therapy are programs. Monthly touchpoints, follow-up labs, dose adjustments, and a clinical reason to stay engaged. The same patient who visits three times a year for neurotoxin may interact with the practice monthly on a GLP-1 protocol.
That is the commercial case: you are not acquiring new patients so much as deepening the ones you have, at a materially higher annual value.
What it actually requires in Texas
Texas applies the corporate practice of medicine doctrine, and prescribing changes your obligations. The pieces:
- An MD or DO medical director, signing protocols and immediately available for consultation.
- Prescribers with capacity. A PA or APRN prescribing needs a prescriptive authority agreement — and those count against the supervising physician’s statutory cap. Confirm capacity before you hire.
- Written delegation and protocols specific to weight management and hormone therapy. Your injectables protocol does not cover semaglutide.
- A real evaluation before any prescription. A licensed provider assesses candidacy — and some patients will not be candidates.
- Labs. Hormone therapy without baseline and follow-up labs is not a defensible program. Weight management is materially better with them.
- Pharmacy sourcing that is documented rather than a relationship with a rep.
- Monitoring and follow-up built into the schedule, not left to the patient.
Where the margin actually is — and is not
Operators usually model this as product markup. That is the smallest and least durable part of it.
| Lever | Why it matters |
|---|---|
| Visit frequency | Monthly contact versus quarterly changes annual value more than price does |
| Retention | Programs with monitoring retain; refill-only models churn |
| Sourcing leverage | Menu discipline and group volume beat per-unit haggling |
| Labs in-house | Removes the drop-off point where send-outs lose patients |
| Cross-sell | The weight-management patient is already an aesthetics patient |
| Provider utilisation | Async review for routine follow-ups reserves provider time for real decisions |
The practices that struggle are the ones that treat this as a product line. The ones that do well treat it as a clinical program that happens to be profitable.
The mistakes that cost money
- Starting before the structure exists. Unwinding is more expensive than building.
- A prescriber who is already at the agreement cap. Found out after the hire.
- Approving everyone. A program that never declines a patient is not evaluating them, and it is the first thing that looks wrong on review.
- No follow-up structure. Refills without monitoring are a liability that also churns.
- Menu sprawl. Five concentrations across three compounds fragments your volume and kills your pricing leverage.
- Outcome marketing. “Lose 20 pounds guaranteed” is both an advertising problem and a clinical one.
Build it or partner for it
Building in-house means recruiting a physician with capacity, drafting protocols, standing up an evaluation workflow, negotiating pharmacy and lab relationships, and maintaining all of it as rules change. That is a real operating function.
Partnering moves it to a group that already runs it. You keep your brand, your patients, and your economics on the commercial side; the clinical entity carries the clinical responsibility.
What MDside provides in Texas
A Texas-licensed MD or DO of record with confirmed capacity, protocols written to your menu, licensed providers performing the evaluations and prescribing, 503A and 503B pharmacy relationships, lab integration including in-house draws, and the review workflow running on software we build and own.
You add the service line without becoming a compliance department. See what is included, or read about bringing labs on site.
Frequently asked questions
Can my Texas med spa add GLP-1 weight management?
Yes, with the right structure: an MD or DO medical director, prescribers with capacity under their prescriptive authority agreements, protocols specific to weight management, and a real evaluation before any prescription.
Do I need labs for a weight-management program?
They are strongly advisable for weight management and effectively necessary for hormone therapy. Drawing on site removes the step where most programs lose patients.
How do I lower medication costs?
Consolidate the menu, commit to forecastable volume, and buy through a group rather than as a single location. Sourcing leverage comes from aggregation, not negotiation skill.
How long does it take to launch?
It depends on physician capacity, protocol scope, and pharmacy and lab setup. Anyone quoting a fixed timeline before asking what you offer is guessing.
Who owns the patient relationship?
Clinically, the professional entity that employs the providers and holds the records. Commercially, your brand remains yours — that separation is the point of the structure.
General information, not legal, clinical, or financial advice. Texas requirements and prescriptive authority rules change. Confirm with healthcare counsel licensed in Texas.